Page URL:
CONTENTS Issue #1129
Whole Genome Sequencing at Birth: What Research Can, and Should, Be Done with a Baby's Genome?
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 

Visit the BioNews website at where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Whole Genome Sequencing at Birth: What Research Can, and Should, Be Done with a Baby's Genome?
24 January 2022 - by Annabel Slater
Genomics England's Newborn Genomes Programme will explore the benefits, practicalities, and challenges of whole genome sequencing for newborn babies in the UK. The genomic data will be used to develop diagnostics and treatments for hundreds of diseases, particularly rare conditions... [Read More]
Newly discovered protein essential for CRISPR/Cas3 genome editing
24 January 2022 - by Tom Turner
A hidden component of the CRISPR/Cas3 genome editing system, which is essential for it to work, has been discovered by scientists... [Read More]
Victorian state government apologises for, and reverses, IVF treatment pause
24 January 2022 - by Joseph Hawkins
The government in Victoria, Australia has reinstated fertility treatment services 'paused' due to COVID-19 in the state at the beginning of January... [Read More]
NHS pilot to test polygenic scores as a screening tool
24 January 2022 - by Dr Rachael Boyle
The NHS has launched a world-first pilot study of predictive genomic testing for the prevention of cardiovascular disease... [Read More]
Weight loss may not bring fertility benefits for obese women
24 January 2022 - by Farah Alam
Losing weight prior to fertility treatment may not increase obese women's chance of having a baby, according to new research... [Read More]
More gene variants that influence severity of COVID-19 identified
24 January 2022 - by Semyon Bodian
Gene variants that decrease and increase the risk of severe COVID-19 infection, respectively, have been identified in separate studies... [Read More]
Light shed on de novo mutations behind male infertility
24 January 2022 - by Georgia Stimpson
Mutations in genes that are involved in sperm production have been highlighted as a potential cause of infertility in affected men... [Read More]
TV Review: Masters of None – Season three
24 January 2022 - by Dr Helen Robertson
The third season of the Netflix series Master of None pivots from the two prior comedic seasons to focus on pursuing motherhood: first as a lesbian couple, and then as a single woman... [Read More]
Video Review: Will I Be Able to Have Children After My Treatment?
24 January 2022 - by Francesca Sowerbutts
Cancer treatments like chemotherapy and radiotherapy often cause substantial loss of the cells responsible for creating gametes, meaning they can cause patients to become infertile... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX